Cross-Regulation of Intracellular cGMP and cAMP in Cultured Human Corpus Cavernosum Smooth Muscle Cells

Author： Kim N.N.   Huang Y-h.   Moreland R.B.   Kwak S.S.   Goldstein I.   Traish A.  

Publisher： Academic Press

ISSN： 1522-4724

Source： Molecular Cell Biology Research Communications, Vol.4, Iss.1, 2000-07, pp. : 10-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The goal of this study was to assess the potential cross-regulation of cyclic nucleotides in human corpus cavernosum (HCC). Incubation of primary cultures of HCC smooth muscle cells with either the NO donor sodium nitroprusside (SNP, 10 μM) or the phosphodiesterase type 5 (PDE 5) inhibitor sildenafil (50 nM) produced little or no changes in the intracellular cGMP levels. Incubation with both SNP and sildenafil produced marked increases in cGMP. Interestingly, incubation of cells with 10 μM of forskolin or PGE1 produced significant enhancement of cGMP accumulation. These increases were not further enhanced by the addition of SNP and sildenafil. Kinetic analyses of cGMP hydrolysis by PDE 5 showed that high concentrations of cAMP reversibly inhibited the enzyme with a Ki of 258 ± 54 μM. The increase in cGMP levels in response to cAMP generating agents is not due to assay artifact since cAMP did not cross-react with cGMP antibody. Our data suggest that cAMP up-regulates intracellular levels of cGMP, in part, by inhibition of PDE 5. We also noted that cGMP down-regulates cAMP synthesis via a mechanism requiring G-protein coupling of adenylyl cyclase. These observations may have important implications in the utility of pharmacotherapeutic agents targeting cyclic nucleotide metabolism for the treatment of erectile dysfunction.

Related content

Regulation of Human PDE5A2 Intronic Promoter by cAMP and cGMP: Identification of a Critical Sp1-Binding Site

By Lin C-S.   Chow S.   Lau A.   Tu R.   Lue T.F.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 3, 2001-01 ,pp. : 693-699 (7)

Elsevier

Access to resources Recommend Favorite

Characterization and Phosphorylation of PDE10A2, a Novel Alternative Splice Variant of Human Phosphodiesterase That Hydrolyzes cAMP and cGMP

By Kotera J.   Fujishige K.   Yuasa K.   Omori K.  

Biochemical and Biophysical Research Communications, Vol. 261, Iss. 3, 1999-08 ,pp. : 551-557 (7)

Elsevier

Access to resources Recommend Favorite

Suppression of Proliferation of Human Coronary Artery Smooth Muscle Cells by the Nitric Oxide Donor, S-Nitrosoglutathione, Is cGMP-Independent

By Young D.V.   Serebryanik D.   Janero D.R.   Tam S.W.  

Molecular Cell Biology Research Communications, Vol. 4, Iss. 1, 2000-07 ,pp. : 32-36 (5)

Academic Press

Access to resources Recommend Favorite

Smooth Muscle alpha-Actin Expression in Rat Hepatic Stellate Cell Is Regulated by Nitric Oxide and cGMP Production

By Kawada N.   Kuroki T.   Uoya M.   Inoue M.   Kobayashi K.  

Biochemical and Biophysical Research Communications, Vol. 229, Iss. 1, 1996-12 ,pp. : 238-242 (5)

Elsevier

Access to resources Recommend Favorite

Glucose-Induced Down-Regulation of NO Production and Inducible NOS Expression in Cultured Rat Aortic Vascular Smooth Muscle Cells: Role of Protein Kinase C

By Nishio E.   Watanabe Y.  

Biochemical and Biophysical Research Communications, Vol. 229, Iss. 3, 1996-12 ,pp. : 857-863 (7)

Elsevier

Access to resources Recommend Favorite